Rochester,NY 7/13/2009 11:46:49 PM
Afternoon Stock Report - CELG - Celgene Corporation to Announce Second Quarter Results on July 23, 2009 - Sourced WhisperFromWallStreet.com
Celgene Corporation
Celgene Corporation, CELG
Celgene Corporation (NASDAQ: CELG - News) senior management will host a conference call and live audio webcast on Thursday, July 23, 2009 at 9 a.m. EDT to discuss the company’s second quarter financial and operational results. The webcast will be available in the investor relations section of the company's Web site at www.celgene.com.
Celgene Corporation, headquartered in Summit, New Jersey, is an integrated global biopharmaceutical company engaged primarily in the discovery, development and commercialization of novel therapies for the treatment of cancer and inflammatory diseases through gene and protein regulation. For more information, please visit the company's Web site at www.celgene.com
ABOUT - Celgene Corporation
Celgene Corporation engages in the discovery, development, and commercialization of innovative therapies to treat cancer and immune-inflammatory related diseases primarily in Europe and the United States. Its primary commercial stage products include REVLIMID for the treatment in combination with dexamethasone for multiple myeloma patients, as well as for the treatment of patients with transfusion-dependent anemia; and THALOMID for the treatment in combination with dexamethasone of patients with newly diagnosed multiple myeloma, as well as for the treatment and suppression of cutaneous manifestations of erythema nodosum leprosum.
Last Trade: 46.60
Day's Range: 45.27 - 46.92
52wk Range: 36.90 - 77.39
Volume: 1,526,781
During 2009 we have sent 40+ alerts with an average gain of over 80%. Below are a few alerts sent only to our whisperfromwallstreet.com members.
SPNG 1800%
AMNG 241%
RKBD 300%
UTRM 169%
TLLE 266%
Sign up now to receive free stock alerts
Please Read Our Disclaimer at http://whisperfromwallstreet.com/disclaimer.php
